Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center.

Hypofractionated SRT is an effective treatment approach for patients with progressive glioblastoma. Younger patients who progressed later than 14 months, received higher SRT doses, and experienced pseudoprogression following SRT had improved survival rates.